Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Salix Pharmaceuticals - Bear of the Day
Oct 22, 2008 10:46 AM
- Salix Pharma Hurt by Generics - Analyst Blog
Oct 20, 2008 02:35 PM
- Analyst Comments: Align Tech, DeVry, Eni SpA, Finisar, Hospira, McDonald, Cleveland-Cliffs, Marlin Biz, Mobile TeleSystems, Salix Pharma, Potash Corp
Sep 10, 2008 05:47 PM
- Analyst Comments: Optimer Pharma, CREE, Delphi Financial, VeraSun, InterDigital, Greenfield Online
Aug 14, 2008 01:10 AM
- Analyst Comments: Huntington Bank, Dow Chemical, DuPont Co, Tessera, SanDisk, Salix Pharma, McDonald, Freeport
Jun 03, 2008 02:05 PM
- Analyst Comments: VeriSign, Metabolix, Cabot Oil, Optimum, American Axle, Superior Industries
May 12, 2008 11:15 PM
- Analyst Comments: Somaxon, Bellus Health, Qiagen, CNET Networks, Salix Pharma, VeriFone
May 07, 2008 05:47 PM
- Analyst Comments: Montpelier Re, Waddell & Reed, MannKind, Genentech, Arkansas Best, Tejon Ranch, Salix Pharma, Forest Oil, LM Ericsson
Apr 11, 2008 06:34 PM
- Analyst Comments: Banco de Chile, American Axle, Optimer Pharmaceuticals, Boston Properties, Kimberly-Clark, PartnerRe
Mar 28, 2008 12:07 PM
- Analyst Comments: Smith Micro, Unisys Corporation,Kroger,Salix Pharmaceuticals
Mar 07, 2008 10:33 AM
- FDA Extends METOZOLV™ ODT Review Date
Nov 18, 2008 12:32 PM
- Salix Announces Issuance of U.S. Patent for Rifaximin
Nov 18, 2008 11:03 AM
- Salix Pharmaceuticals to Present at Credit Suisse Conference
Nov 06, 2008 07:01 AM
- Salix Pharmaceuticals Reports 3Q2008 Results
Nov 05, 2008 04:09 PM
- APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
Nov 03, 2008 07:00 AM
- APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
Oct 31, 2008 03:53 PM
- Salix Pharmaceuticals Announces 3Q2008 Financial Results Conference Call and Webcast
Oct 22, 2008 07:01 AM
- Zacks Bull and Bear of the Day Highlights: PetMed Express, Salix Pharmaceuticals, Brasil Telecom, Campbell Soup and HDFC Bank
Oct 22, 2008 12:17 AM
- Data Released Today Demonstrate That Mesalamine Granules Maintain Remission in Ulcerative Colitis Patients Who Switch from Another 5-ASA
Oct 07, 2008 08:11 AM
- Data Released Today Demonstrate That Mesalamine Granules Maintain Remission in Ulcerative Colitis Patients Who Switch From Another 5-ASA
Oct 07, 2008 08:01 AM
- Form 3 DEERFIELD INTERNATIONAL For: Nov 21 (10K)
Nov 21, 2008 04:47 PM
- Form 4 DEERFIELD INTERNATIONAL For: Oct 18 (10K)
Oct 21, 2008 10:19 PM
- Form 3 SALIX PHARMACEUTICALS For: Oct 09 Filed by: DEERFIELD MANAGEMENT CO /NY (10K)
Oct 14, 2008 03:16 PM
- Form 4 Reeth Mark D For: Jul 01 (10K)
Jul 03, 2008 09:44 AM
- Form 4 LOGAN CAROLYN J For: Jul 01 (10K)
Jul 03, 2008 09:41 AM
- Form 4 Forbes William P For: Jul 01 (10K)
Jul 03, 2008 09:37 AM
- Form 4 DERBYSHIRE ADAM C For: Jul 01 (10K)
Jul 03, 2008 09:36 AM
- Form 4 Sirgo Mark A For: Jul 01 (10K)
Jul 03, 2008 09:32 AM
- Form 4 KEANE WILLIAM P For: Jul 01 (10K)
Jul 03, 2008 09:29 AM
- Form 4 HARRAL WILLIAM III For: Jul 01 (10K)
Jul 03, 2008 09:26 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
SLXP
|
Compare to S&P
|
| YTD |
-8.25 %
|
-0.01 %
|
| 4 Weeks |
-21.16 %
|
-6.66 %
|
| 12 Weeks |
10.72 %
|
71.98 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 26.67 %
|
|
EPS Growth in Last Year: -137.93 %
|
|
Sales Growth in Last Quarter: 4.39 %
|
|
Sales Growth in Last Quarter: -36.36 %
|
|
|
